AlphaLens
Research
研报Overweight5月6日 · Morgan Stanley

Korea Renaissance: SK Square Co Ltd.: The Purest Proxy to SK hynix

中文EN⚠ quality lint: see notes

Korea Renaissance: SK Square Co Ltd.: The Purest Proxy to SK hynix

Core Thesis

SK Square offers a leveraged, pure-proxy exposure to SK hynix (20.1% stake, ~90-98% of NAV) combined with a separate return driver: a management-led plan to compress the holding company discount from ~56% to <30% by 2028. The stock trades at current price of W1,089,000 (May 6, 2026), implying a 3.6x 2026E P/E and 0.8x 2028E P/B. With a SOTP-based price target of W1,300,000, upside is ~19%. The bull case assuming 25% discount yields W1,500,000 (+38%). The bear case using current hynix price and 65% discount yields W570,000 (-48%). The investment case is inseparable from the memory upcycle but enhanced by Korea’s Value-Up initiative and activist-driven shareholder return commitments.

Evidence Chain: Pure Proxy and Leveraged Exposure

SK Square’s NAV is overwhelmingly driven by SK hynix. As of May 2026, the hynix stake accounted for 98% of total NAV (W244tr out of W249tr). Equity method gains from hynix flow through SK Square’s operating profit, making earnings a high-beta mirror of hynix. The stock shows a 0.996 correlation coefficient with hynix over recent periods. In downturns, effective beta is ~1.1-1.2x due to leverage inherent in the holdco structure. Non-core assets (TMAP Mobility, SK Shieldus, 11STREET, ONE Store) are collectively negligible—the “Others” bucket contributes just W0.43tr to NAV. These subsidiaries are mostly loss-making or early-stage, representing long-term optionality but no near-term earnings support. Revenue from consolidated entities (Commerce, Mobility, Platform) is dilute to margins. Thus, SK Square’s equity value is a concentrated call on hynix, amplified by the holdco discount.

Evidence Chain: Discount Compression via Value-Up and Buybacks

Management has adopted a transparent, KPI-linked framework: reduce NAV discount to <30% and achieve P/B >1.0x by 2028. The CEO’s compensation is explicitly tied to these targets. The first milestone (discount <50% by 2027) was reached ahead of schedule in 2025, demonstrating execution credibility. Capital allocation centers on sustained buyback-cancels funded by asset monetization. Over the past two years, SK Square streamlined from >40 subsidiaries to ~16. In 2025, it executed ~W300bn in buyback-cancels. The company committed to a W2tr shareholder return program for 2026-28, based on at least 30% of recurring dividend income plus a portion of investment performance. A one-time capital reserve conversion of W5.89tr in 2026 removes regulatory constraints on distributions.

The discount compression thesis is benchmarked against global holdco peers. Prosus narrowed its discount from 54% (June 2022) to ~33% (March 2024) — a 21ppt compression in under two years — via open-ended buybacks funded by Tencent stake sales. SK Square is approximately three years behind on this trajectory. Investor AB trades near zero discount (sometimes premium) due to decades of disciplined capital allocation, independent governance, and uninterrupted dividend growth. Korean holdco discounts historically widened to 60-70% after minority-unfriendly events (Samsung C&T/Cheil merger, LG Chem split). SK Square differs: it was created as a professionally managed investment holdco, not a family-control vehicle. Its board includes five independent directors (one foreign national) and CEO KPIs are shareholder-return focused. Foreign ownership >50% of free float, and activists Pallisar Capital and Third Point have amplified market pressure. The Korean government’s tax incentives for holdco transitions (CGT deferral until end-2026, dividend exclusion) further support restructuring momentum.

Key Risks

The thesis is vulnerable to memory cycle downturns. A hard-landing in HBM or DRAM pricing would directly impair SK hynix’s earnings and NAV, while SK Square’s effective beta of 1.1-1.2x magnifies losses. Capital misallocation remains a risk: unexpected large investments in unlisted holdings or M&A could derail buyback momentum and widen the discount. The discount compression itself is not guaranteed — if management fails to sustain buyback-cancels or slows asset sales, the discount could re-widen (bear case assumes 65% discount). Additionally, Korea’s holdco discount is a structural remnant of past minority-unfriendly practices; market trust may require a 3-5 year track record. Non-core subsidiaries (TMAP, 11STREET) are still loss-making and may require capital support.

Valuation & Trade Implications

Base case SOTP applies a 35% discount to NAV based on management’s 2028 target trajectory, yielding W1,300,000. Bull case (25% discount) of W1,500,000 is only 5ppt more aggressive than the CEO’s 30% target and reflects the potential if execution continues at pace. Bear case uses SK hynix’s current market price (W1,447,000) and a 65% discount (reflecting cycle trough pessimism) to derive W570,000. The risk-reward skew is asymmetric: upside to bull case is +38%, downside to bear case is -48%, but the probability of bear case materialization requires a simultaneous negative shock to both hynix fundamentals and holdco discount widening. Current valuation at 2028E P/B of 0.8x and FCF yield of ~40% already embeds substantial discount. The trade is best implemented with an explicit understanding of the leverage effect: a 20% decline in hynix would likely translate to a 22-25% decline in SK Square before discount expansion. Monitoring hynix’s FCF trajectory (2026 FCF could reach ~2x current levels) and buyback execution cadence is essential for timing entry and exits.